Astrana Health, Inc. (ASTH)
USD 35.04
(-1.35%)
USD 35.04
(-1.35%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 214.95 Million USD | 7.76% |
| 2022 | 199.47 Million USD | 12.21% |
| 2021 | 177.77 Million USD | 719.04% |
| 2020 | 21.7 Million USD | -70.88% |
| 2019 | 74.53 Million USD | -46.56% |
| 2018 | 139.47 Million USD | 117.87% |
| 2017 | 64.01 Million USD | 0.0% |
| 2015 | 9.69 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 68.86 Million USD | 76.65% |
| 2024 Q2 | 66.01 Million USD | -4.13% |
| 2023 Q1 | 47.84 Million USD | 29.23% |
| 2023 Q4 | 38.98 Million USD | -46.45% |
| 2023 Q2 | 55.33 Million USD | 15.65% |
| 2023 Q3 | 72.79 Million USD | 31.56% |
| 2023 FY | 214.95 Million USD | 7.76% |
| 2022 Q2 | 35.27 Million USD | -7.54% |
| 2022 FY | 199.47 Million USD | 12.21% |
| 2022 Q4 | 37.02 Million USD | -48.2% |
| 2022 Q3 | 71.47 Million USD | 102.63% |
| 2022 Q1 | 38.15 Million USD | 102.42% |
| 2021 Q4 | 18.84 Million USD | -74.86% |
| 2021 Q2 | 35.18 Million USD | 0.0% |
| 2021 Q3 | 74.97 Million USD | 113.07% |
| 2021 FY | 177.77 Million USD | 719.04% |
| 2020 FY | 21.7 Million USD | -70.88% |
| 2019 FY | 74.53 Million USD | -46.56% |
| 2018 FY | 139.47 Million USD | 117.87% |
| 2017 FY | 64.01 Million USD | 0.0% |
| 2015 FY | 9.69 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 68.509% |
| Addus HomeCare Corporation | 339.87 Million USD | 36.754% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | -76.332% |
| Amedisys, Inc. | 457.07 Million USD | 52.971% |
| American Oncology Network, Inc. | 66.05 Million USD | -225.413% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 63.899% |
| IMAC Holdings, Inc. | 3.84 Million USD | -5485.33% |
| biote Corp. | 127.48 Million USD | -68.617% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -838.624% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | 50.248% |
| COMPASS Pathways plc | -242.93 Thousand USD | 88582.658% |
| DocGo Inc. | 178.95 Million USD | -20.121% |
| The Ensign Group, Inc. | 590.75 Million USD | 63.613% |
| Healthcare Services Group, Inc. | 251.45 Million USD | 14.513% |
| InnovAge Holding Corp. | 132.06 Million USD | -62.768% |
| Assure Holdings Corp. | -2.19 Million USD | 9897.539% |
| The Joint Corp. | 107.14 Million USD | -100.614% |
| LifeStance Health Group, Inc. | 302.09 Million USD | 28.844% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 20158.695% |
| ModivCare Inc. | 446.95 Million USD | 51.906% |
| NewGenIvf Group Limited | 1.68 Million USD | -12681.539% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | -4240.205% |
| Option Care Health, Inc. | 981.22 Million USD | 78.093% |
| P3 Health Partners Inc. | 31.63 Million USD | -579.494% |
| P3 Health Partners Inc. | 31.63 Million USD | -579.494% |
| The Pennant Group, Inc. | 61.9 Million USD | -247.233% |
| Surgery Partners, Inc. | 529.4 Million USD | 59.396% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -15124.733% |
| Talkspace, Inc. | 74.38 Million USD | -189.0% |
| Talkspace, Inc. | 74.38 Million USD | -189.0% |
| The Oncology Institute, Inc. | 59.57 Million USD | -260.831% |
| The Oncology Institute, Inc. | 59.57 Million USD | -260.831% |